The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
Clinical trial NCT05873803 · UNKNOWN
Trial details
- NCT number
- NCT05873803
- Sponsor
- Genrix (Shanghai) Biopharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-08
- Primary completion
- 2024-10-30
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.